We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
+9.45%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$10.1B
AUM Growth
-$32.7M
Cap. Flow
-$129M
Cap. Flow %
-1.28%
Top 10 Hldgs %
46.32%
Holding
595
New
41
Increased
67
Reduced
176
Closed
32

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$24.6M
2
PAYC icon
Paycom
PAYC
+$13.6M
3
VEEV icon
Veeva Systems
VEEV
+$11M
4
NVDA icon
NVIDIA
NVDA
+$2.69M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$2.23M

Top Sells

Rank Stock Value
1
MA icon
Mastercard
MA
+$19.8M
2
HDB icon
HDFC Bank
HDB
+$13.2M
3
FISV
Fiserv Inc
FISV
+$10.3M
4
PYPL icon
PayPal
PYPL
+$9.75M
5
MSFT icon
Microsoft
MSFT
+$9.65M

Sector Composition

Rank Sector Weight
1 Technology 38.51%
2 Healthcare 17.03%
3 Consumer Discretionary 10.46%
4 Financials 10.36%
5 Communication Services 7.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IQLT icon
376
iShares MSCI Intl Quality Factor ETF
IQLT
$14.3B
$62.4K ﹤0.01%
+1,642
New +$62.6K
LSXMK
377
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$61.9K ﹤0.01%
2,508
– –
SEIC icon
378
SEI Investments
SEIC
$12.7B
$60.3K ﹤0.01%
900
– –
SWAV
379
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$59.1K ﹤0.01%
180
+85
+89% +$20.9K
VLO icon
380
Valero Energy
VLO
$95.9B
$58.1K ﹤0.01%
350
– –
SJM icon
381
J.M. Smucker
SJM
$12.8B
$57.9K ﹤0.01%
493
– –
CRSP icon
382
CRISPR Therapeutics
CRSP
$5.2B
$57.6K ﹤0.01%
1,035
– –
SRE icon
383
Sempra
SRE
$56.8B
$56.9K ﹤0.01%
800
– –
SLF icon
384
Sun Life Financial
SLF
$44.8B
$56.7K ﹤0.01%
1,100
-200
-15% -$10.6K
ATR icon
385
AptarGroup
ATR
$8.43B
$56.1K ﹤0.01%
400
– –
SWKS icon
386
Skyworks Solutions
SWKS
$10.4B
$55.8K ﹤0.01%
569
– –
NEM icon
387
Newmont
NEM
$121B
$55.6K ﹤0.01%
1,485
– –
LRCX icon
388
Lam Research
LRCX
$420B
$53.8K ﹤0.01%
620
+560
+933% +$49.3K
MTRN icon
389
Materion
MTRN
$5.91B
$53.7K ﹤0.01%
457
– –
HUM icon
390
Humana
HUM
$46.2B
$53.7K ﹤0.01%
165
– –
C icon
391
Citigroup
C
$233B
$51.8K ﹤0.01%
850
– –
DG icon
392
Dollar General
DG
$26.9B
$51.4K ﹤0.01%
360
– –
MRNA icon
393
Moderna
MRNA
$25.7B
$51.2K ﹤0.01%
490
– –
OXY.WS icon
394
Occidental Petroleum Corp Warrants
OXY.WS
$33.3B
– –
0
– –
LH icon
395
Labcorp
LH
$26.1B
$50.8K ﹤0.01%
250
– –
CATC
396
DELISTED
CAMBRIDGE BANCORP
CATC
$50.5K ﹤0.01%
805
– –
BAX icon
397
Baxter International
BAX
$14B
$49.5K ﹤0.01%
1,225
– –
LKQ icon
398
LKQ Corp
LKQ
$6.27B
$48.9K ﹤0.01%
1,000
– –
VNLA icon
399
Janus Henderson Short Duration Income ETF
VNLA
$3.36B
$48.5K ﹤0.01%
1,004
– –
VTRS icon
400
Viatris
VTRS
$18.7B
$47.7K ﹤0.01%
4,243
– –
14 15
16
17 18

Similar funds

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return
URS
Utah Retirement Systems Salt Lake City, Utah $9.78B AUM 28.72% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, Loring Wolcott & Coolidge Fiduciary Advisors held 595 positions worth $10.1B, down 0.32% from $10.1B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q1 2024 filing shows 41 new, 67 increased, 176 reduced and 32 closed positions. Its largest new stake was GE Vernova: 3,494 shares worth $478K. The largest sale was Mastercard, an estimated $19.8M.

By sector, the portfolio is most concentrated in Technology at 39% of assets, down from 40% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q1 2024 buy was GE Vernova: 3,494 shares worth $478K.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to Regeneron Pharmaceuticals in Q1 2024, an estimated $24.6M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q1 2024 reduction was Mastercard, cutting an estimated $19.8M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited Wheaton Precious Metals in Q1 2024, selling an estimated $497K.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 46% of its $10.1B portfolio in Q1 2024.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 41 new positions and closed 32 in Q1 2024.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value fell 0.32% quarter-over-quarter to $10.1B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q1 2024, filed 23 Apr 2024.